Harnessing Artificial Intelligence to Enhance Global Breast Cancer Care: A Scoping Review of Applications, Outcomes, and Challenges
Open Access
Abstract
Background: In recent years, Artificial Intelligence (AI) has shown transformative potential in advancing breast cancer care globally. This scoping review seeks to provide a comprehensive overview of AI applications in breast cancer care, examining how they could reshape diagnosis, treatment, and management on a worldwide scale and discussing both the benefits and challenges associated with their adoption. Methods: In accordance with PRISMA-ScR and ensuing guidelines on scoping reviews, PubMed, Web of Science, Cochrane Library, and Embase were systematically searched from inception to end of May 2024. Keywords included “Artificial Intelligence” and “Breast Cancer”. Original studies were included based on their focus on AI applications in breast cancer care and narrative synthesis was employed for data extraction and interpretation, with the findings organized into coherent themes. Results: Finally, 84 articles were included. The majority were conducted in developed countries (n = 54). The majority of publications were in the last 10 years (n = 83). The six main themes for AI applications were AI for breast cancer screening (n = 32), AI for image detection of nodal status (n = 7), AI-assisted histopathology (n = 8), AI in assessing post-neoadjuvant chemotherapy (NACT) response (n = 23), AI in breast cancer margin assessment (n = 5), and AI as a clinical decision support tool (n = 9). AI has been used as clinical decision support tools to augment treatment decisions for breast cancer and in multidisciplinary tumor board settings. Overall, AI applications demonstrated improved accuracy and efficiency; however, most articles did not report patient-centric clinical outcomes. Conclusions: AI applications in breast cancer care show promise in enhancing diagnostic accuracy and treatment planning. However, persistent challenges in AI adoption, such as data quality, algorithm transparency, and resource disparities, must be addressed to advance the field.Keywords
This publication has 132 references indexed in Scilit:
- A Machine Learning‐Based Unenhanced Radiomics Approach to Distinguishing Between Benign and Malignant Breast Lesions Using T2‐Weighted and Diffusion‐Weighted MRIJournal of Magnetic Resonance Imaging, 2023
- Evaluating ChatGPT as an adjunct for the multidisciplinary tumor board decision-making in primary breast cancer casesArchives of Gynecology and Obstetrics, 2023
- A Channel‐Dimensional Feature‐Reconstructed Deep Learning Model for Predicting Breast Cancer Molecular Subtypes on Overall b‐Value Diffusion‐Weighted MRIJournal of Magnetic Resonance Imaging, 2023
- Deep Learning Model Based on Dual-Modal Ultrasound and Molecular Data for Predicting Response to Neoadjuvant Chemotherapy in Breast CancerAcademic Radiology, 2023
- The diagnostic performance of ultrasound computer-aided diagnosis system for distinguishing breast masses: a prospective multicenter studyEuropean Radiology, 2022
- Deep learning radiomics of ultrasonography can predict response to neoadjuvant chemotherapy in breast cancer at an early stage of treatment: a prospective studyEuropean Radiology, 2021
- A deep learning approach for mitosis detection: Application in tumor proliferation prediction from whole slide imagesArtificial Intelligence in Medicine, 2021
- MRI Radiomics for Assessment of Molecular Subtype, Pathological Complete Response, and Residual Cancer Burden in Breast Cancer Patients Treated With Neoadjuvant ChemotherapyAcademic Radiology, 2020
- Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast CancerJAMA, 2017
- Noninvasive and Low-Cost Technique for Early Detection of Clinically Relevant Breast Lesions Using a Handheld Point-of-Care Medical Device (iBreastExam): Prospective Three-Arm Triple-Blinded Comparative StudyIndian Journal of Gynecologic Oncology, 2016